GB5005 CART-cell Injection in the Treatment of Patients With CD19-positive RR B-NHL

Clinical trial NCT06875063 · RECRUITING

Trial details

NCT number: NCT06875063
Sponsor: The First Affiliated Hospital of Xiamen University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non-hodgkin Lymphoma Refractory Lymphoma Chimeric Antigen Receptor T-cell

Start date: 2026-04-30
Primary completion: 2026-05-31
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.